Oldest pages
From NeuroRehab.wiki
Showing below up to 50 results in range #351 to #400.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- DEMENTIA-ALZHEIMER'S Dz MANAGEMENT (03:41, 21 February 2023)
- CLINICAL-INTERNUCLEAR OPTHALMOPLEGIA (03:41, 21 February 2023)
- PARKINSONS & PARKINSONISM-PELVIC DYSFUNCTION (03:41, 21 February 2023)
- NEUROPATHY-CIDP INVESTIGATIONS (03:41, 21 February 2023)
- CLINICAL-TREMORS (03:41, 21 February 2023)
- MND-POST POLIO SYNDROME (PPS) DIFFERENTIALS (03:41, 21 February 2023)
- DIZZINESS-BPPV, PAGNINI-MCCLURE MANOEUVRE (03:41, 21 February 2023)
- STROKE-EXECUTIVE FUNCTION (NON PHARMACOLOGIC) MGM (03:41, 21 February 2023)
- COMA-INFRATENTORIAL ETIOLOGY (03:41, 21 February 2023)
- SEIZURES-STOPPING MEDICATION (03:41, 21 February 2023)
- MYASTHENIA GRAVIS-MANAGEMENT (03:41, 21 February 2023)
- CLINICAL-ARGYLL ROBERTSON PUPIL (03:41, 21 February 2023)
- NCS-EMG (ABNORMAL RESTING MUSCLE ACTIVITY) (03:41, 21 February 2023)
- GENERALIZED SEIZURE-MANAGEMENT (03:41, 21 February 2023)
- STROKE-tPA MECHANISM (03:41, 21 February 2023)
- CLINICAL-NYSTAGMUS (03:41, 21 February 2023)
- PARKINSONS (MILD TO MODERATE) Tx-MAO B INHIBITOR (03:41, 21 February 2023)
- NEUROPATHY-PATTERNS OF INVOLVEMENT (03:41, 21 February 2023)
- CNS INFECTIONS-CJD (03:41, 21 February 2023)
- MND-VOCATION & FINANCIAL ISSUES (03:41, 21 February 2023)
- STROKE-BRAIN STIMULATION (03:41, 21 February 2023)
- TIA-RISK STRATIFICATION (ABCD2 SCORE) (03:41, 21 February 2023)
- CLINICAL-CAUSES OF ANOSMIA (03:41, 21 February 2023)
- NCS-MOTOR TESTING PARAMETERS (03:41, 21 February 2023)
- PARKINSONS & PARKINSONISM-LSVT BIG (03:41, 21 February 2023)
- STROKE-CT, EARLY FINDINGS (03:41, 21 February 2023)
- MULTIPLE SCLEROSIS-DEPRESSION (03:41, 21 February 2023)
- SEIZURES-ANTI EPILEPTIC TERATOGENS (03:41, 21 February 2023)
- STROKE-MEMORY DEFICIT MANAGEMENT (03:41, 21 February 2023)
- STROKE-PRESENTATION, MIMICS (03:41, 21 February 2023)
- NCS-CIP & CIM INVESTIGATIONS (03:41, 21 February 2023)
- DEMENTIA-ALZHEIMER'S Dz RISK FACTORS (03:41, 21 February 2023)
- PARKINSONS & PARKINSONISM-PHARMACOLOGIC MGM (03:41, 21 February 2023)
- NEUROPATHY-CIDP VARIANTS (03:41, 21 February 2023)
- DERMATOMES-C2 TO C4 (03:41, 21 February 2023)
- MND-POST POLIO SYNDROME (PPS) EXERCISE REGIMEN (03:41, 21 February 2023)
- DIZZINESS-CAUSES OF VERTIGO (03:41, 21 February 2023)
- STROKE-FERTILITY (03:41, 21 February 2023)
- COMA-LOCKED IN SYNDROME (03:41, 21 February 2023)
- MYASTHENIA GRAVIS-MYAESTHENIC CRISIS (03:41, 21 February 2023)
- NCS-EMG (MOTOR UNIT ACTION POTENTIAL, MUAP) (03:41, 21 February 2023)
- STROKE-tPA MEDICATIONS (03:41, 21 February 2023)
- DEMENTIA-DIAGNOSIS (03:41, 21 February 2023)
- PARKINSONS (SEVERE) Tx-L DOPA (03:41, 21 February 2023)
- NEUROPATHY-POLYNEUROPATHY (03:41, 21 February 2023)
- STROKE-BRUNNSTROM STAGES OF MOTOR RECOVERY (03:41, 21 February 2023)
- CLINICAL-CAUSES OF BILATERAL BLINDNESS (03:41, 21 February 2023)
- NCS-NORMAL MOTOR VALUES (03:41, 21 February 2023)
- PARKINSONS & PARKINSONISM-LSVT EVIDENCE (03:41, 21 February 2023)
- MND-FATIGUE MANAGEMENT (03:41, 21 February 2023)